Stethoscope Market Revenue and Value Chain 2020-2024

 The global stethoscope market is expected to grow significantly over the forecast period. It is estimated that the global stethoscope market is expected to register a CAGR ~ 4.6% during the forecast period of 2019 to 2024 with an estimated market value of USD 332.1 million in 2018. 

The global market is driven by factors such as increasing incidence rate of life-threatening diseases, increased spending on healthcare and ongoing research and development. Moreover, growing technological advancements such as Bluetooth connectivity with digital wireless hearing aids is expected to fuel the growth of the market during the assessment period. Furthermore, increasing innovations in the field of healthcare have pushed for the growth of the market. For instance, in October 2018, researchers from Rochester Institute of Technology and University of Rochester Medical Center developed a new electronic stethoscope that combines precision sensors, electrocardiogram technology, and machine learning applications into one piece of equipment to better detect heart ailments and problems that might occur with an implanted heart pump. Similarly, in March 2018, Neurologists from Stanford University developed brain stethoscope that can translate the brain’s activity into sounds so that silent seizures can be detected. On the other hand, poor healthcare system and less access to health services in certain economies are restraining the growth of stethoscope market. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7802 

Moreover, major companies in the market are involved in strategic collaborations to brace their position in the market. For instance, in September 2015, eKuore launched its first wireless stethoscope in Düsseldorf, Germany. 

Regional Analysis

The market in the Americas is expected to dominate the global stethoscope market during the forecast period owing to the increasing per capita healthcare expenditure, heavy implementation of new technology in the region, and increase in product innovation. The US is expected to hold the major share in the market owing to increased technology adoption. For instance, in March 2018, Neurologists from Stanford University, California, developed brain stethoscope that can translate the brain’s activity into sounds so that silent seizures can be detected. Europe is expected to hold the second largest position in the global stethoscope market. The market growth in this region is because of the presence of a well-established healthcare system. The growth in the number of medical personnel is also contributing to the growth in the region. Asia-Pacific is estimated to be the fastest growing region in the market due to the rise in the number of awareness programs. The market in the Middle East & Africa is likely to account for the smallest share of the global stethoscope market. The market growth in this region owes to the low disposable income in the region.

Segmentation

The global stethoscope market has been segmented into type, and end user. The market, based on type, has been segmented into manual stethoscope and electronic stethoscope. The market, by manual stethoscope, has been further segmented into a fetal stethoscope, and others. The market, by electronic stethoscope, has been sub-segmented into esophageal stethoscopes, fetal heart rate detectors, and others. The market, by end user, has been segmented into hospitals, clinics, ambulatory surgical centers, and others. Hospitals are expected to hold a major share in the end user segment owing to the increased incidences of chronic diseases, as well as the rise in the patient visits. Clinics are projected to be the fastest growing segment due to the ease of accessibility it provides to the patients. 

Key Players

Some of the key players in the global stethoscope market are McCoy Medical, 3M, A&D Medical, Rudolf Riester, American Diagnostic Corporation, Cardionics, Omron Corporation, GF Health Products, Heine Optotechnik, Medline Industries, Smith’s Medical, and Welch Allyn.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/stethoscope-market-7802 

Cardiopulmonary Resuscitation Market Analysis and Value Forecast Snapshot by End-use Industry 2020-2027

 Global Cardiopulmonary Resuscitation Market was valued at USD 1,603.16 Million in 2019 and is expected to register a CAGR of 10.50% during the forecast period of 2020 to 2027.

Cardiopulmonary resuscitation (CPR) is a lifesaving technique useful in many emergencies, including a heart attack or near drowning, in which someone's breathing or heartbeat has stopped. During a cardiac arrest, due to an insufficient supply of blood, the heart stops beating. In such conditions, blood circulation vital to sustaining life can be provided by constantly compressing the heart through a physical force applied to the patient’s chest. This rescue technique is termed cardiopulmonary resuscitation (CPR), which is employed in emergencies or conditions to protect the patient from fatal myocardial infarction or brain damage.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1348 

Segment Analysis

Global Cardiopulmonary Resuscitation Market has been divided based on Product Type, Compressor Type, Application, and End User.

The market, based on Product Type, has been segregated into piston CPR devices, load-distributing band (LDB), active compression-decompression (ACD) devices and impedance threshold device, extracorporeal techniques and invasive perfusion devices, and others.

Based on compressor type, the Global Cardiopulmonary Resuscitation Market is segmented into manual CPR and automatic mechanical CPR.

The global market, on the basis of application, has been segmented into emergency departments, coronary & intensive care units, organ transplant facilities, air medevac units, and EMT rescue units.

On the basis of end-user, the market is bifurcated into the hospital & clinic, cardiac catheterization laboratories, organ transplant unit, and others.

Regional Analysis

Global Cardiopulmonary Resuscitation Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to hold the largest share of the global cardiopulmonary resuscitation market during the assessment period owing to the rise in the prevalence of lifestyle diseases and heart diseases. The Europe market is expected to register substantial growth in the market owing to the technological advancements, high disposable income, growing geriatric population, and favorable regulatory framework. Asia-Pacific is likely to hold the third-largest share of the global cardiopulmonary resuscitation market. The market in the Middle East & Africa is expected to witness gradual growth owing to the increasing number of heart & respiratory diseases coupled with rapidly developing healthcare infrastructure.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Cardiopulmonary Resuscitation Market— Stryker, Nihon Kohden Corporation, ZOLL Medical Corporation, Koninklijke Philips N.V., Vyaire Medical, Inc., General Electric Company, CPR Medical Devices, Inc., Michigan Instruments, Corpuls, SCHILLER, and Medtronic.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cardiopulmonary-resuscitation-market-1348 

Interventional Cardiology Market Growth Insight Analysis 2020-2025

 Global Interventional Cardiology Market held a value of USD 15,130.75 Million in 2018 and is expected to register a CAGR of 7.25% during the assessment period of 2019 to 2025.

Interventional Cardiology Market Synopsis

Interventional cardiology deals with the catheter-based treatment of heart diseases. Scrutinizing all the global territories, it has been noticed that there is a huge rise in the number of cardiac diseases. This can be attributed to the change in lifestyle, leading to lifestyle diseases. Each year cardiovascular diseases cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8735 

Many market players are dominating the global interventional cardiology market. The prominent players are involved in strategic agreements, product launches, and joint ventures to brace their market positions. For instance, in May 2018, Terumo Europe NV announced the launch of Ultimate Tensei drug-eluting stent in Europe.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas held maximum share in the base year 2018, owing to the high incidence rates of cardiac disorders and strategic activities by major players in countries such as the US. The interventional cardiology market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European interventional cardiology market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The European market for interventional cardiology is expected to hold a substantial share owing to the increase in the number of cardiac disorder cases. For instance, in 2016, there were 66,076 deaths due to coronary heart diseases in the UK, which was the third-highest cause of death in that particular year. The interventional cardiology market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The interventional cardiology market in this region is anticipated to be the fastest-growing during the forecast period due to the increasing uptake and adoption rate of newer treatment options by patients as well as medical professionals. The increasing patient pool and mortality rate due to cardiac diseases in these countries also fuel the market growth. For instance, in 2017, ischemic heart disease was the second-highest cause for death in Japan. The interventional cardiology market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Interventional Cardiology Market has been segmented based on Type, and End User.

The market, based on type, has been segmented into stents, percutaneous transluminal coronary angioplasty (PTCA) catheters, plaque modification devices, coronary guidewires, and accessories. The market, based on stents, has been further divided into drug-eluting stents, bare-metal stents, and bioresorbable vascular scaffolds. The stents segment held a major share in 2018 owing to the increased number of product launches by key players in the current years. This segment is also expected to be the fastest-growing segment during the forecast period due to the increasing prevalence of coronary artery disease, and continued innovations by players. The market, based on PTCA catheters, has been segmented into balloon catheters, and guiding catheters.

The Global Interventional Cardiology Market has been segmented, based on end-user, into hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and others. In 2018, the hospital's segment held the majority share of the market owing to the increasing number of patient admissions due to coronary diseases. The cardiac catheterization laboratory segment is projected to be the fastest-growing segment owing to the increasing preference of cath labs by medical professionals.

Key Players

Some of the Key Players in the Global Interventional Cardiology Market are ABIOMED (US), Abbott (US), ACIST Medical Systems, Inc. (the US), B. Braun Melsungen AG (Germany), BD (US), Biosense Webster, Inc (US), Biotronik SE & Co. KG (Germany), Boston Scientific Corporation (US), Cardinal Health (US), Cook Medical (US), Edwards Lifesciences Corporation (US), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Life Vascular Devices Biotech S.L. (Spain), Medtronic (Ireland), Merit Medical Systems, Inc (US), Terumo Corporation (Japan), and W. L. Gore & Associates, Inc. (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/interventional-cardiology-market-8735 

Vitamin K2 Market – Future Need Assessment 2023

 Vitamin K2, also known as menaquinones, are a group of compounds known for preventing cardiovascular diseases and bone diseases. The vitamin is responsible for ensuring calcium is absorbed by the bone matrix and prevent its deposition in the arteries.

The global vitamin K2 market is estimated to touch a valuation of USD 228.27 million by 2023, as per the latest findings of Market Research Future (MRFR). It is predicted to register 31.08%% CAGR over the forecast period (2018-2025). It was previously valued at USD 45 million in 2017. It is primarily driven by the rise in vitamin deficiency cases. An increase in health consciousness coupled with the inclination of consumers towards nutritional supplements can drive the vitamin K2 market growth.

Rising cases of osteoporosis which can accelerate the aging of tissues is another factor that can positively impact the market. But strict regulations by government federal agencies for approval of supplements can act as a growth deterrent.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7495 

Segmentation

The global vitamin K2 market is segmented by product type, source, form, and application.

By product type, MK-7 accounted for 71.61% market share in 2017, followed by MK-4 (21.87%) and others (6.52%). The MK-7 segment can touch a value of USD 165.91 million by 2023. On the other hand, MK-4 can accrue USD 48.93 million at a CAGR of 30.63% during the forecast period.

By source, natural accounted for 64.88% share and synthetic accounted for 35.12% share in 2017 respectively. The natural source is expected to exhibit 30.72% CAGR during the forecast period to touch a size of USD 145.73 million by 2023. On the other hand, the synthetic segment is projected to reach USD 82.54 million by 2023, growing at 31.73% CAGR over the assessment period.

By form, powder held 52.75% share in 2017, followed by oil (36.96%) and others (10.29%). The powder form can accrue revenue worth USD 117.89 million by 2023, exhibiting 30.62% CAGR during the review period. The oil segment can display the strongest CAGR of 32.61% over the assessment period to reach a size of USD 90.43 million by 2023. This can be credited to its effective dosage method for supplying K2 successfully.

Among applications, nutraceutical & food accounted for 85.46% share in 2017, while pharmaceutical held 14.54% share. The pharmaceutical segment can exhibit 32.05% CAGR during the forecast period to generate USD 34.69 million for the vitamin K2 market by 2023. On the other hand, the nutraceutical & food segment is projected to exhibit 30.91% CAGR to generate close to USD 193.57 million by 2023.

Regional Analysis:

Geographically, the vitamin K2 market is segmented into Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA). Americas dominated the market with 42.93% market share in 2017, followed by Europe (38.87%), APAC (14.65%), and MEA (3.55%).

The APAC region can generate close to USD 31.11 million by 2023, growing at 29.51% CAGR over the forecast period. This can be attributed to its huge consumption by the population in China, India, and Australia.

On the other hand, the Europe vitamin K2 market can reach a valuation of USD 94.50 million by 2023. It can exhibit the fastest CAGR of 32.45% during the assessment period. The Americas region can generate 97.01 million by 2023 owing to youth and geriatric populace focused on safeguarding their health. The MEA region can experience a modest growth rate owing to government-backed campaigns which emphasize on citizen wellness.

Competitive Analysis:

Major players in the vitamin K2 market include Kyowa Hakko Bio Co. Ltd. (Japan), DSM (The Netherlands), Gnosis SpA (Italy), Frutarom (Israel), Kappa Bioscience (Norway), Danisco A/S (U.S.), Seebio Biotech (China), NattoPharma (Norway), Viridis BioPharma (India), and Geneferm Biotechnology Co. Ltd. (Taiwan). Collaborations, investments in R&D, and expansions are strategies incorporated by these players to increase their profit margins. In November 2018, Kappa Bioscience gained a license to import vitamin K2 based drugs, K2VITAL DELTA. The intake of these pills can reduce hardening in the arteries and reduce the probability of cardiovascular diseases.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/vitamin-k2-market-7495 

Pharmaceutical Filtration Market Statistics Analysis 2022

 Filtration in pharmaceutical has been used to purify or separate the component and also to maintain the sterile conditions during the process to prevent contamination. Various methods are being used for filtration depends on the component that need to be filtered. Major factors such as increasing growth of pharmaceutical industry and rapid growth in the generic drug production are the main reasons driving the market growth. On the other hand the huge capital required to set up new production facilities and stringent government regulations to legalize the filtration process are expected to limit market growth to a certain extent. Globally, the market is growing rapidly and it is anticipated to show an exponential growth reaching approximately $23 Billion in 2022.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2432 

Segments:     
The pharmaceutical filtrations market has been segmented on the basis of type of filtrations, product, and their application in pharmaceutical industry. On the basis of type the market has been segmented as air filtration, water filtration, chemical filtrations, Grade filtration (liquid and gas), and absorptive filtrations. Similarly on the basis of product, the market has been segmented into membrane filters, media filters, cartridges and capsule filtration and others. On the basis of application in pharmaceutical industry the filtrations market has again segment into air purification, water purification, sterilization, cell separation, media and buffer filtrations and others.

Regional Analysis of Pharmaceutical filtration devices Market:
Considering the global scenario of the market, Americas region is believed to be the largest market for Pharmaceutical filtration techniques and devices. Moreover the European market is also growing continuously and slowly catching up with the American market. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the pharmaceutical filtration devices segment during the forecasted period. Middle East & Africa region are likely to have a limited but steady growth in the market.

Key Players for Pharmaceutical filtrations devices Market:                       
Some of the key players in this market are: GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech S.A. (France), Merck KGaA (Germany), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), and GEA Group (Germany).

The report for Pharmaceutical Filtrations Devices Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/pharmaceutical-filtration-devices-market-2432 

Patient Handling Equipment Market: Industry Size, Trends and Analysis – Growth Revenue And Cost Analysis With Key Company’s Profiles, Forecast To 2027

 Global Patient Handling Equipment Market is expected to be valued at USD 15,430.18 Million by 2027 at a CAGR of 8.3% during the forecast period, 2020-2027.

The advancement in patient handling equipment and expansion of healthcare infrastructure due to the COVID-19 pandemic is expected to boost the growth of the market in the forecast period.

Market Synopsis

An increasing usage of patient handling equipment in hospitals, rehabilitation centers, and elderly care settings is expected to drive the growth of the global patient handling equipment market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9986 

The market growth in the coming years can also be attributed to the business expansion of manufacturers through merger & acquisition and incessant launch of innovative products. For instance, in the year 2020, Invacare Corporation, a US-based long-term medical product manufacturer, announced the launch of an Invacare AVIVA FX Power Wheelchair, a front-wheel-drive wheelchair. This product launch was aimed to strengthen the company’s power mobility product portfolio.

Market USP

Growing patient population of chronic diseases and rising geriatric population are the major market influencer of the patient handling equipment market.  

Market Drivers

The rising influx of patients in the hospital due to an outbreak of COVID-19 pandemic. The critical care products including hospital beds, ventilators, and vitals monitoring devices are being used in abundance for patients suffering from COVID-19. Various companies are aiding the healthcare sector in meeting the rising demand for critical care products by increasing their manufacturing capacity. For instance, in May 2020, Stryker (US) delivered about 1,000 emergency relief beds to hospitals in Qatar. The company is also massively producing emergency relief beds, a low-cost hospital bed.      

• Increasing geriatric and obese population

• Risk of injuries to caregivers while manual handling of patients

• Implementation of regulations to ensure the safety of healthcare service providers during the manual lifting procedure. For instance, according to the Office of State Human Resources (OSHR), the caregiver should do a preliminary assessment of their safety & health risks before any manual handling operation and take appropriate steps to lower the risks of patient handling. Also, manual handling operations should be avoided as far as it is reasonably practicable.

• A growing number of road accidents

• Growing usage of ceiling lifts in hospitals

Market Restraints

• Low skilled professionals for the efficient operation of the patient handling equipment.

Segmentation

By Product

• Patient Transfer Devices: This segment is likely to hold the largest share owing to the growing number of obese patients. This segment is further fragmented into patient lifts, air-assisted lateral transfer mattresses, sliding sheets, and accessories. Patient transfer devices aid in long and short distance transfer of patients depending on the requirement. Also, these products provide caregivers reduced risk of injuries while patient handling and are time efficient. According to National Public Radio, every year about 35,000 nursing professionals experience back and body injuries during patient handling in the US region.

• Medical Beds: This segment is further segmented into manual beds, electric beds, and semi-electric beds. The rising number of COVID-19 patients has influx the demand for medical beds in the forecast period. Also, the growing geriatric population base susceptive to chronic disease will be driving the growth of the segment. For instance, in 2019, according to the United Nations, globally there were about 703 million people aged 65 or over.

• Mobility Devices: This segment is further segmented into wheelchairs & mobility scooters, and ambulatory aids. The increasing cases of disability are expected to propel the demand for mobility devices. The ambulatory aid equipment provides support, stability, and balance for patients. The ambulatory aid segment includes equipment such as crutch, cane walking, walker, and others.

• Bathroom & Toilet Assist Equipment: These segments include bathroom assist products such as commodes, bath aids, handgrips, bath lifts, shower chairs, and others. Easy availability in online stores is likely to propel the growth of the segment.

• Stretchers & Transport Chairs: These are used in carrying patients from one place to another, within and outside of a healthcare facility. The advancement in stretchers & transport chairs has been enabling clinicians in providing patients with proper emergency assistance.

By Application

• Acute & Critical Care: This segment is likely to hold the largest share owing to high prevalence rate cardiovascular diseases, viral infection, and other acute diseases. For instance, in 2017, according to the Centers for Disease Control and Prevention (CDC), about 18.2 million adult population aged 20 or older were suffering from coronary heart disease in the US region.

• Long Term Care: This segment is likely to be the fastest-growing segment owing to the growing prevalence of target diseases such as tuberculosis, Alzheimer’s disease, tetanus, and others. For instance, according to Alzheimer's Association, in the US, about 5.8 million people aged 65 or above were suffering from Alzheimer’s dementia in 2019 and 5.7 million in 2018.

• Mobility Assistance: The growth of this segment can be attributed to the growing incidence rate of diseases such as arthritis and Parkinson’s.  For instance, according to Parkinson's Foundation, every year about 60,000 of the American population are diagnosed with Parkinson’s disease. This disease is characterized by stiffness, slowed movement, tremors, and impaired balance. The mobility assistance devices improve balance and provide support to patients suffering from Parkinson’s disease. Also, the rising elderly population is expected to drive the growth of the segment.

By End-User

• Hospitals: Hospitals segment dominated the market share owing to increasing healthcare infrastructure and rising investment. According to MRFR analysis, the investments made in hospital and healthcare services for the year 2017 and 2018 in some European countries are the following:

By Region

• Americas: The largest regional market. The increasing prevalence rate of obesity is expected to boost the growth of the market during the forecast period. For instance, in the US, according to the Centers for Disease Control and Prevention (CDC), in 2017-18, the prevalence of obesity was around 42.2%, which was about 39.8% in 2015-16.

• Europe: Europe held the second-largest position in the patient handling equipment market owing to high research and development investment. For instance, in 2017, according to MedTech Europe, about 40% of total patent applications in medical technology were filed from European countries.

• Asia-Pacific: The fastest-growing regional market for patient handling equipment owing to the growing life expectancy rate. According to the World Bank, the life expectancy at birth in the South Asia region in 2017 and 2018 were 69.1 year and 69.4 years, respectively. Also, growing healthcare expenditure is driving the growth of the market. For instance, in 2017, according to the World Bank, the healthcare expenditure of Japan, China and India was about 10.94%, 5.15%, and 3.53%, respectively. Such increasing expenditure backed by life expectancy rate is expected to boost the demand for patient handling devices in the coming years

• Middle East & Africa: This region is expected to show steady growth owing to the high rate of obesity. For instance, in 2016, according to the World Health Organization, about 28.3% of adults and 81.3% of women are suffering from obesity in the South African region. However, low healthcare infrastructure in the region is expected to hinder the market growth in the forecast period.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/patient-handling-equipment-market-9986 

Laboratory Equipment Market Growth, Demands, CAGR, Sales Volume, Opportunities, Types, Applications and Forecast up to 2023

 Laboratory equipment market is on track to secure a growth rate of 7.3% from 2019 to 2025 (evaluation period), says Market Research Future (MRFR). The MRFR study also expects the market to touch USD 58,960 Million by 2025.  

Top Boosters and Challenges

The laboratory equipment industry benefits the large-scale investments in extensive research and development activities in the field of biotechnology and pharmaceutical. The market is also strongly influenced by the increasing availability of advanced laboratory supplies and their growing use by procurement managers in industries like healthcare and pharmaceutical. Innovations in chemical and biological researches combined with the surge in clinical laboratory tests along with life science researches can also foster market growth in the ensuing period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8365 

Introduction of new technologies and their adoption have been picking up speed in the market, thereby facilitating enhanced laboratory capabilities. Adoption of modern techniques is proving to be favorable for scientists and laboratory technicians as they are able to achieve more efficient and accurate results. Automation, artificial intelligence, miniaturization and smart technology are the prevailing trends and are witnessing high demand among laboratory equipment manufacturers.

Medical lab equipment vendors are putting in efforts to facilitate simpler order processes and product selection, whereas laboratory managers are working on bolstering the efficiency by elevating the purchasing process. The trend of easy to use and compact equipment with built-in connectivity is also emerging at a promising rate, while the construction of new labs with advanced equipment and supplies by renowned companies can induce substantial market growth in the years ahead

Segmental Analysis

The laboratory equipment industry has been segregated with respect to product type, application, and end user.

The product types studied are centrifuges, incubators, scopes, spectrometers, autoclaves, sonicators, and others. The incubators segment can obtain the top spot in the global market, as the device’s application range is expanding in several areas of testing. The spectrometers segment could procure the fastest expansion rate.

The laboratory equipment market, with respect to application, comprises genetic testing, endocrinology, biochemistry, hematology, microbiology, and more. The biochemistry segment is slated to capture the highest share in the market, owing to the significant number of biochemical tests that are generally conducted in laboratories. The endocrinology category is confirmed to advance at the fastest pace, on account of the expanding patient pool and the surge in the number of tests.

The end users considered in the report include diagnostic centers, hospitals and clinics, and more. The hospitals and clinics sector can take the lead in the market as these end-users extensively use a variety of laboratory equipment. The diagnostic centers segment can however, advance at the fastest rate in the forthcoming years, as a result of the rising preference for conducting diagnostic tests by medical professionals, with the use of highly advanced lab equipment and supplies.

Regional Study

The market for laboratory equipment has been regionally distributed on the basis of the Americas, MEA or the Middle East & Africa, APAC/Asia Pacific, and Europe.

Americas has been identified as the most lucrative market, while the US and Canada are in the lead in the region due to their highly developed laboratories with modern equipment as well as instruments. Strong presence of a number of renowned biopharmaceutical and pharmaceutical companies that are actively involved in extensive R&D activities will further bolster the region’s attractiveness in the coming years. A few other growth boosting factors include the soaring number of grants including NIH or National Institute of Health that aim to encourage researches in the region.

APAC should procure the fastest CAGR in the near future, thanks to the surging cases of infectious diseases such as AIDS, tuberculosis and hepatitis that require accurate laboratory testing. Escalating burden of cancer in the region, especially in India and China can also benefit the market in the upcoming years.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/laboratory-equipment-market-8365